“Safety and Efficacy of Risankizumab in the Treatment of Chronic Plaque-Type Psoriasis: A Pilot Single-Arm, Single-Center, Prospective Cohort Study”, Bang. Armed Forces Med. J., vol. 58, no. 1, pp. 22–29, Nov. 2025, doi: 10.3329/bafmj.v58i1.84958.